98%
921
2 minutes
20
Infectious coryza is a major respiratory disease of chickens induced by Avibacterium paragallinarum. Understanding the prevalent serovars of the bacterium is fundamental for effective prevention and control of the disease. Moreover, improving the immune efficacy of the infectious coryza vaccine for laying hens under modern production systems is critical for disease management. Enterococcus faecium is a probiotic bacterium. However, the impact of E. faecium on infectious coryza vaccine efficacy has not been investigated. In this study, we isolated and identified Av. paragallinarum strains from chickens with suspected infectious coryza in farms in central China between 2019 and 2022. Serotyping was performed based on the haemagglutinin HMTp210 gene sequence. Seventy-two strains were isolated, including 19 strains of serovar A-1, 44 strains of serovar C-4, and six strains of serovar B. Three strains were non-serotypable. Av. paragallinarum loads in palatine clefts of the flocks were detected using qPCR targeting the recN gene which revealed increasing loads with age that stabilized at 31 weeks of age (5.59 × 10³ CFU/g). Healthy Hy-Line Grey laying hens were immunized with the infectious coryza vaccine at six weeks of age, and E. faecium TC3 was added to feed at a concentration of 10 CFU/g. Blood samples were collected 28 days post-immunization to assess antibody titers, cytokine levels, and other immune parameters. Immunoprotective efficacy was evaluated by challenge with serovar A-1 and C-4 isolates. Addition of E. faecium significantly increased infectious coryza vaccine antibody levels and enhanced protective efficacy against A-1 and C-4 strains by 6.72 % and 7.07 %, respectively. Furthermore, morbidity rates decreased by 33.53 % and 24.77 % in A-1 and C-4 strains, respectively. These findings indicate that E. faecium improves infectious coryza vaccine efficacy and strengthens the health of chicken flocks.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.psj.2025.105622 | DOI Listing |
Front Public Health
September 2025
Department of Family and Community Medicine, Penn State University College of Medicine, Hershey, PA, United States.
Background: The World Health Organization recommends at-home management of mild COVID-19. While our preliminary evaluation provided evidence for saline nasal irrigation (SNI) and gargling in COVID-19, an update and risk-benefit assessment for self-care in Omicron infection is warranted, from treatment and preparedness perspectives, as new SARS-CoV-2 variants continuously emerge, while symptoms overlap with those of common colds and other upper respiratory tract infections.
Methods: Systematic literature searches for preclinical and clinical studies involving Omicron infection and saline, bias assessment, and review of outcomes (benefits, risks).
PLoS Pathog
September 2025
Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Frontiers Science Center of Pathogenic Microorganisms and Infection, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
Coronaviruses, including SARS-CoV-2, rely on host factors for their replication and pathogenesis, while hosts deploy defense mechanisms to counteract viral infections. Although numerous host proviral factors have been identified, the landscape of host restriction factors and their underlying mechanisms remain less explored. Here, we conducted genome-wide CRISPR knockout screens using three distinct coronaviruses-SARS-CoV-2, HCoV-OC43 (a common cold human virus from the genus Betacoronavirus) and porcine epidemic diarrhea virus (Alphacoronavirus) to identify conserved host restriction factors.
View Article and Find Full Text PDFBio Protoc
August 2025
Department of Microbiology & Immunology, Dalhousie University, Halifax, NS, Canada.
Human coronavirus OC43 (HCoV-OC43) is an endemic "common cold" coronavirus widely used to study fundamental aspects of coronavirus biology and to test therapeutic interventions. Recently, we used a yeast-based reverse genetics strategy to create recombinant HCoV-OC43 and fluorescent reporter viruses. We assembled a DNA copy of the HCoV-OC43 genome from six linear dsDNA fragments and a linearized yeast centromeric plasmid/bacterial artificial chromosome (YCpBAC) vector in using transformation-associated recombination (TAR).
View Article and Find Full Text PDFNat Commun
August 2025
HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
As intrinsic differences in humoral immune response to SARS-CoV-2 between children and adults remain unclear, we improved characterisation by defining the kinetics, specificity and function of antibodies to SARS-CoV-2 in children (n = 146, aged 9.4 ± 4.8 years with n = 257 samples) compared to adults (n = 85, aged 39.
View Article and Find Full Text PDFMicrobiol Resour Announc
August 2025
Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, Iowa, USA.
is a primary bacterial pathogen causing infectious coryza (IC), a respiratory disease of chickens. However, nonpathogenic (npAP) has been discovered in naive, healthy chickens, complicating IC diagnosis. Here, we report eight complete and four draft genome sequences of npAP isolates from four US states.
View Article and Find Full Text PDF